1. Objective Definition

Melatonin is a neurohormone primarily produced by the pineal gland, a small endocrine gland located deep in the center of the brain. Often referred to as the “hormone of darkness,” its fundamental role is to communicate the timing of environmental light-dark cycles to the rest of the body. It acts as a master biological signal that regulates the circadian rhythm, the internal 24-hour clock that governs sleep-wake patterns, core body temperature, and various metabolic processes.

2. Mechanism of Action

The production and release of melatonin follow a specific, light-sensitive pathway:

• Photoreception: Light enters the eyes and stimulates the retina. This signal is transmitted to the Suprachiasmatic Nucleus (SCN), the brain’s master clock.
• Inhibition and Stimulation: During daylight, the SCN sends signals to inhibit the production of melatonin. When the environment becomes dark, the SCN ceases this inhibition, prompting the pineal gland to begin secretion.
• Circulation: Melatonin is released directly into the bloodstream and cerebrospinal fluid.
• Receptor Binding: It binds to specific receptors (MT1 and MT2) located throughout the body, including the brain, cardiovascular system, and immune cells.
• Downstream Effects: Binding to these receptors signals to the body that it is in the “biological night” phase. This leads to a decrease in core body temperature and an increase in sleep propensity (the physiological readiness for sleep).

3. Historical and Development Context

Melatonin was first isolated and identified in 1958 by Dr. Aaron Lerner at Yale University. Initially, researchers were interested in its effect on skin pigmentation, as it was found to lighten the skin of amphibians. However, by the 1970s, the focus shifted toward its role in mammalian circadian biology. Scientists discovered that its production was strictly tied to light exposure, leading to its current status as the primary biomarker for studying human biological rhythms and sleep disorders.

4. Observed Data & Documented Findings

Extensive clinical research has documented the following regarding melatonin:

• Phase Shifting: Studies consistently show that exogenous (supplemental) melatonin can shift the timing of the internal clock, which is why it is often studied in relation to jet lag and shift work.
• Sleep Latency: Meta-analyses of clinical trials indicate that melatonin can reduce “sleep onset latency”—the time it takes to fall asleep—particularly in individuals with Delayed Sleep Phase Disorder.
• Elderly Production: Observational studies have noted that endogenous melatonin production often declines with age, which correlates with changes in sleep architecture in older populations.
• Secondary Sites: Research has confirmed that melatonin is also produced in smaller quantities in the gastrointestinal tract and retina, where it may act as a local antioxidant or paracrine signal.

5. The Two-Sided View: Balance Table

6. What We Know vs. What We Don’t Know

What science is confident about:

• Melatonin is essential for signaling biological night to the body.
• Light exposure, especially blue light, acutely suppresses melatonin production.
• Supplements can effectively “reset” the clock when used at the correct biological time.

What is still debated or unclear:

• The optimal dosage for different age groups (standardized dosing is not yet established).
• The long-term effects of daily exogenous use over several years.
• Its efficacy for “primary insomnia” compared to circadian-based sleep disorders.

References

1. Melatonin: What You Need To Know — National Institutes of Health (NIH)

https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know

2. Melatonin and the Biological Clock — National Library of Medicine (NCBI)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334454

3. Circadian Rhythms and Sleep — Harvard Medical School (Division of Sleep Medicine)

https://sleep.hms.harvard.edu/education-training/public-education/sleep-and-health-education-program/essential-reading-0